debridement News
-
How is open fracture treated
Usually we will be in the fracture, combined with the coverage of the fracture site of the skin and subcutaneous soft tissue injury fracture, fracture end and the outside of the same fracture called open fracture. Open fracture is faced with commonly the place that suffer an injury is broken, its difficulty rises relatively bigger also, so, how should open fracture be dealt with after all? ...
-
Vericel to Present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 7:30 a.m. Eastern Time. A webcast of the presentation will be available on the Investor Relations section of the Vericel ...
-
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present at the Canaccord Genuity Musculoskeletal Conference in Chicago, IL on Tuesday, March 22nd at 11:00 a.m. Central Time. A webcast of the presentation will be available on the Investor Relations section of the ...
-
Vericel to Present at the Cowen 42nd Annual Health Care Conference on March 9, 2022
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will participate in a fireside chat at the Cowen 42nd Annual Health Care Conference on Wednesday, March 9th at 1:30 p.m. Eastern Time. A webcast of the presentation will be available on the Investor Relations section of ...
-
Vericel to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference on September 13th, 2021
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021, at 4:15p.m. Eastern Time. A webcast of the presentation will be available on the ...
-
Vericel to Present at the Ladenburg Thalmann Healthcare Conference on Tuesday, July 13, 2021
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present the latest company overview at the Ladenburg Thalmann Healthcare Conference. The conference is being conducted in a virtual format and the presentation will take place on Tuesday, July 13, 2021, at 9:00 a.m. ...
-
Axio Biosolutions receives another FDA clearance for Axiostat Patch for Vascular Bleeding Control
Axio Biosolutions, an integrated wound care company has announced FDA 510(k) clearance of its hemostatic product, Axiostat Patch that helps control moderate to severe bleeding in vascular procedures, surgical debridement sites, puncture sites and more. Axiostat Hemostatic Patch is based on a protonated bioadhesive technology which works by providing a strong mechanical barrier to the injury ...
-
Vericel to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on November 18th, 2021
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on Thursday November 18th, at 10:00a.m. Eastern Time. A webcast of the presentation will be available on the Investor ...
-
Additive Implants Announces FDA Clearance for SureMAX-X Cervical Spacer
Additive Implants, Inc. is pleased to announce it received regulatory clearance to market in the US its second product, the SureMAX®-X Cervical Spacer. This 3D printed titanium spacer has a unique patented* design to create uniform end plate coverage and optimize load distribution. “Maximizing implant coverage of the endplates and providing for more uniform load distribution is ...
-
Vericel Announces Plans for a New State-of-the-Art Cell Therapy Manufacturing Facility to Support Long-Term Growth
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it has entered into a long-term lease agreement for a new state-of-the-art advanced cell therapy manufacturing and corporate headquarters facility at the Network Drive campus at Northwest Park in Burlington, Massachusetts. The new facility, which will ...
-
Additive Implants Announces FDA Clearance for SureMAX-X Cervical Spacer
Additive Implants, Inc. is pleased to announce it received regulatory clearance to market in the US its second product, the SureMAX®-X Cervical Spacer. This 3D printed titanium spacer has a unique patented* design to create uniform end plate coverage and optimize load distribution. “Maximizing implant coverage of the endplates and providing for more uniform load distribution is ...
-
Vericel Expands Executive Leadership Team and Announces Appointment of Patrick Fowler as Senior Vice President, Corporate Development and Strategy
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, announced the appointment of Patrick J. Fowler as Senior Vice President, Corporate Development and Strategy, effective today. Mr. Fowler joins Vericel with over 15 years of business development, strategy and commercial operations experience in the biotech and medical technology ...
-
Basic ENT Surgery Set
Otorhinolaryngology is the medical specialty that deals with conditions of the ear, nose, and throat (ENT). Surtex Instruments manufacture the diverse instruments of the basic ENT surgery set to provide the best tools for the commonest diagnostic and therapeutic procedures in otolaryngology. The set includes three figures of Mod. Vienna Nasal Speculum with different blade lengths to offer ...
-
CognitOss Granted FDA Breakthrough Device Designation
FDA’s Breakthrough Device Program helps accelerate patient access to more effective treatments Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to CognitOss, currently in develoment for the treatment of chronic osteomyelitis. The FDA Breakthrough Device ...
-
Microlyte Matrix and Microlyte Surgical featured in clinical research presented at SAWC
Imbed Biosciences is proud to announce that research conducted using Microlyte Matrix and Microlyte Surgical will be presented in a panel discussion at SAWC, a national wound healing conference. Imbed Biosciences announced today that clinical results documenting the use of its products, Microlyte® Matrix and Microlyte® SURGICAL, will be presented at the Fall Symposium on Advanced Wound ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you